Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in ~60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize t...
Saved in:
| Main Authors: | Martin Fassnacht, Matthias Kroiss, Laura-Sophie Landwehr, Barbara Altieri, Jochen Schreiner, Iuliu Sbiera, Isabel Weigand, Silviu Sbiera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000469.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltration
by: Tanja Maier, et al.
Published: (2025-03-01) -
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
by: Katia Mariniello, et al.
Published: (2025-06-01) -
The treatment and prognosis of pediatric adrenocortical carcinoma
by: Yu Lin, et al.
Published: (2025-08-01) -
Validation of a Fecal Glucocorticoid Assay to Assess Adrenocortical Activity in Meerkats Using Physiological and Biological Stimuli.
by: Ines Braga Goncalves, et al.
Published: (2016-01-01) -
The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma
by: Sun Kyung Baek, et al.
Published: (2024-10-01)